Please check for further notifications by email. Social Disadvantage, Politics, and SARS-CoV-2 Trends: A County-Level Analysis of United States Data
Please enable it to take advantage of the complete set of features! Silverchair Information Systems 2014;9(3):299-305. doi: 10.2217/fmb.13.167.Antibiotics (Basel). Name must be less than 100 characters
There is an accumulating amount of literature reporting successful use of minocycline intravenous for treatment of serious MDR Acinetobacter infections, particularly for nosocomial pneumonia. doi: 10.1093/cid/ciu706.Karageorgopoulos DE, Kelesidis T, Kelesidis I, Falagas ME.J Antimicrob Chemother.
2016 Oct;76(15):1467-1476. doi: 10.1007/s40265-016-0636-6.Future Microbiol. 2019 Aug;46:193-201. doi: 10.1016/j.ebiom.2019.07.041. Clin Infect Dis. Unable to load your collection due to an error Minocycline works effectively when used for Acinetobacter colonies in lung, meninges, soft tissue, and blood. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.Oxford University Press is a department of the University of Oxford. doi: 10.1093/cid/ciz830.Front Microbiol. There is an accumulating amount of literature reporting successful use of minocycline intravenous for treatment of serious MDR Acinetobacter infections, particularly for nosocomial pneumonia. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwideFor full access to this pdf, sign in to an existing account, or purchase an annual subscription. Search for other works by this author on:
Central nervous system safety during brief analytic treatment interruption of antiretroviral therapy within four HIV remission trials: an observational study in acutely treated people living with HIV
Thank you for submitting a comment on this article. Epub 2008 Apr 24.Clin Infect Dis. David J. Ritchie, Alexandria Garavaglia-Wilson, A Review of Intravenous Minocycline for Treatment of Multidrug-Resistant Options for treatment of multidrug-resistant (MDR) One of the classes of antibiotics being explored for treatment of MDR This article will briefly discuss the microbiology, pharmacokinetics, pharmacodynamics, and tolerability of minocycline, and also review the available literature evaluating use of minocycline intravenous specifically for treatment of MDR In common with other tetracyclines, minocycline inhibits bacterial protein synthesis through binding with the 30S subunit of the bacterial ribosome, most typically resulting in a bacteriostatic effect.
Following reintroduction of minocycline to the market for the treatment of serious infections, including an FDA-approved indication for infections caused by Acinetobacter, there has been renewed interest in its use.
Unable to load your delegates due to an error Higher Completion Rates with Self-administered Once-weekly Isoniazid-Rifapentine versus Daily Rifampin in Adults with Latent Tuberculosis
2019 Aug 16;7:233. doi: 10.3389/fpubh.2019.00233. Griffith et al reported a case series of 8 patients with specifically defined traumatic wound infections with presumptive osteomyelitis caused by MDR Minocycline is, in general, well tolerated. Antibiotic Overuse after Hospital Discharge: A Multi-Hospital Cohort Study
Hudson Valley, New York
Search for other works by this author on:
Structural vulnerability to COVID-19 among Latinx communities in the United States
You have entered an invalid code
All rights reserved.
Correspondence: David J. Ritchie, PharmD, FCCP, BCPS, Barnes-Jewish Hospital and St. Louis College of Pharmacy, Mailstop 90-52-411, 216 S Kingshighway Blvd, St Louis, MO 63110 (
Bad bugs, no drugs: no ESKAPE! © The Author 2014.
Silverchair Information Systems
The authors tested the efficacy of minocycline against 5477 A. baumanii and other gram-negative pathogens to arrive at the above conclusion.